{"id":39977,"date":"2026-02-12T19:46:42","date_gmt":"2026-02-12T19:46:42","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/investigational-new-drug-cdmo-market-mordor\/"},"modified":"2026-04-03T00:58:52","modified_gmt":"2026-04-02T15:58:52","slug":"investigational-new-drug-cdmo-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/investigational-new-drug-cdmo-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \uc784\uc0c1\uc2dc\ud5d8\uc6a9 \uc2e0\uc57d CDMO \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2025 &#8211; 2030)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/investigational-new-drug-cdmo-market_1696325676245_IND_CDMO_Key_Players.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/investigational-new-drug-cdmo-market-size-image-1735473283722.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \uc5ed\ud559<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \uc81c\uc57d \uc0b0\uc5c5\uc758 \uc784\uc0c1\uc2dc\ud5d8\uc6a9 \uc2e0\uc57d \uc2e0\uccad \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.2 R&amp;D \ud22c\uc790 \uc99d\uac00<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \uc544\uc6c3\uc18c\uc2f1 \uad00\ub828 \uaddc\uc815 \uc900\uc218 \ubb38\uc81c<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.4.1 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.4.2 \uad6c\ub9e4\uc790\/\uc18c\ube44\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.4.3 \uacf5\uae09\uc5c5\uccb4\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.4.4 \ub300\uccb4 \uc81c\ud488\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.4.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uc138\ubd84\ud654 (\uc2dc\uc7a5 \uaddc\ubaa8 &#8211; USD \uac00\uce58)<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \uc81c\ud488\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 \uc800\ubd84\uc790<\/li>\n<li class=\"toc-level-4\">5.1.1.1 \uc6d0\ub8cc\uc758\uc57d\ud488 (API)<\/li>\n<li class=\"toc-level-4\">5.1.1.2 \uc644\uc81c\uc758\uc57d\ud488<\/li>\n<li class=\"toc-level-3\">5.1.2 \uace0\ubd84\uc790<\/li>\n<li class=\"toc-level-4\">5.1.2.1 \ud3ec\uc720\ub958<\/li>\n<li class=\"toc-level-4\">5.1.2.2 \ubbf8\uc0dd\ubb3c<\/li>\n<li class=\"toc-level-4\">5.1.2.3 \uae30\ud0c0<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \uc11c\ube44\uc2a4\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \uc704\ud0c1 \uac1c\ubc1c<\/li>\n<li class=\"toc-level-3\">5.2.2 \uc704\ud0c1 \uc0dd\uc0b0<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \uc81c\uc57d \ud68c\uc0ac<\/li>\n<li class=\"toc-level-3\">5.3.2 \uc0dd\uba85\uacf5\ud559 \ud68c\uc0ac<\/li>\n<li class=\"toc-level-3\">5.3.3 \uae30\ud0c0<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.4 \uc9c0\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.4.1 \ubd81\ubbf8<\/li>\n<li class=\"toc-level-4\">5.4.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.4.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.4.1.3 \uba55\uc2dc\ucf54<\/li>\n<li class=\"toc-level-3\">5.4.2 \uc720\ub7fd<\/li>\n<li class=\"toc-level-4\">5.4.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.4.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.4.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.4.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.4.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.4.2.6 \uae30\ud0c0 \uc720\ub7fd<\/li>\n<li class=\"toc-level-3\">5.4.3 \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-4\">5.4.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.4.3.2 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.4.3.3 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.4.3.4 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.4.3.5 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.4.3.6 \uae30\ud0c0 \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-3\">5.4.4 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.4.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.4.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.4.4.3 \uae30\ud0c0 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-3\">5.4.5 \ub0a8\ubbf8<\/li>\n<li class=\"toc-level-4\">5.4.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.4.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.4.5.3 \uae30\ud0c0 \ub0a8\ubbf8<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<p>is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is is<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\uc784\uc0c1\uc2dc\ud5d8\uc6a9 \uc2e0\uc57d(IND) CDMO \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d: \uc131\uc7a5, \ub3d9\ud5a5 \ubc0f \uc608\uce21 (2025-2030)<\/p>\n<p>1. \uc2dc\uc7a5 \uac1c\uc694 \ubc0f \uc131\uc7a5 \uc804\ub9dd<\/p>\n<p>\uc784\uc0c1\uc2dc\ud5d8\uc6a9 \uc2e0\uc57d(Investigational New Drug, IND) CDMO(Contract Development and Manufacturing Organization) \uc2dc\uc7a5\uc740 2025\ub144 47\uc5b5 4\ucc9c\ub9cc \ub2ec\ub7ec \uaddc\ubaa8\ub85c \ucd94\uc815\ub418\uba70, 2030\ub144\uc5d0\ub294 65\uc5b5 1\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0 \uc774\ub97c \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc608\uce21 \uae30\uac04(2025-2030\ub144) \ub3d9\uc548 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR)\uc740 6.55%\ub97c \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc774 \uc2dc\uc7a5\uc740 \uc81c\uc57d \ubc0f \uc0dd\uba85\uacf5\ud559 \uc0b0\uc5c5\uc5d0\uc11c \uc544\uc6c3\uc18c\uc2f1 \uc11c\ube44\uc2a4\uc5d0 \ub300\ud55c \uc218\uc694 \uc99d\uac00, \uc5f0\uad6c \uac1c\ubc1c(R&#038;D) \ud65c\ub3d9\uc758 \ud65c\ubc1c\ud654, \uadf8\ub9ac\uace0 \uc6b0\ud638\uc801\uc778 \uc815\ubd80 \uc9c0\uc6d0\uc5d0 \uc758\ud574 \uc8fc\ub85c \uc131\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc774 \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc2dc\uc7a5\uc774 \ub420 \uac83\uc774\uba70, \ubd81\ubbf8 \uc9c0\uc5ed\uc740 \uac00\uc7a5 \ud070 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \uc720\uc9c0\ud560 \uac83\uc73c\ub85c \ubcf4\uc785\ub2c8\ub2e4. \ud604\uc7ac \uc2dc\uc7a5 \uc9d1\uc911\ub3c4\ub294 \uc911\uac04 \uc218\uc900\uc73c\ub85c \ud3c9\uac00\ub429\ub2c8\ub2e4.<\/p>\n<p>2. \uc2dc\uc7a5 \ub3d9\uc778<\/p>\n<p>\uc81c\uc57d \ubd80\ubb38\uc5d0\uc11c \uc544\uc6c3\uc18c\uc2f1\uc740 \ube44\uc6a9 \uc808\uac10, \uc138\uacc4\ud654, \uaddc\uc81c \uc900\uc218, \uc2e0\uc57d \uac1c\ubc1c \uac00\uc18d\ud654, \uac00\uc0c1 \ubc0f \ud558\uc774\ube0c\ub9ac\ub4dc \ube44\uc988\ub2c8\uc2a4 \ubaa8\ub378 \ub3c4\uc785, \uae30\uc220 \ubc1c\uc804, \uc704\ud5d8 \uad00\ub9ac \ub4f1 \uc5ec\ub7ec \uc694\uc778\uc73c\ub85c \uc778\ud574 \ud575\uc2ec \ube44\uc988\ub2c8\uc2a4 \uc804\ub7b5\uc73c\ub85c \ubd80\uc0c1\ud588\uc2b5\ub2c8\ub2e4. \uc544\uc6c3\uc18c\uc2f1\uc740 \uc0c8\ub85c\uc6b4 \uae30\uc220 \uc811\uadfc, \uac00\ubcc0 \ube44\uc6a9 \uc808\uac10, \uc704\ud5d8 \uacf5\uc720 \ub4f1 \ub2e4\uc591\ud55c \uc0dd\uc0b0\uc131 \uc774\uc810\uc744 \uc81c\uacf5\ud558\uba70, \uacc4\uc57d \uc81c\uc870\ub97c \ud1b5\ud574 \uc0c1\ub2f9\ud55c \ube44\uc6a9 \uc808\uac10\uc774 \uac00\ub2a5\ud569\ub2c8\ub2e4. \ub610\ud55c, \uc5ec\ub7ec \uacf5\uae09\uc5c5\uccb4 \uad00\ub9ac\uc758 \ubcf5\uc7a1\uc131\uc744 \uc904\uc774\uace0 \uc778\uac74\ube44\ub97c \ud06c\uac8c \uc808\uac10\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc2e4\uc81c\ub85c, 2023\ub144 10\uc6d4 Ampio Pharmaceuticals Inc.\ub294 \uc99d\uc0c1\uc131 \uace8\uad00\uc808\uc5fc \ud1b5\uc99d \uce58\ub8cc\ub97c \uc704\ud55c \uc2e0\uc57d OA-201\uc758 \uc784\uc0c1 \uac1c\ubc1c\uc744 \uc9c0\uc6d0\ud558\uae30 \uc704\ud574 CDMO\uc778 Ascendia Pharmaceuticals Inc.\ub97c \uc120\uc815\ud558\uc5ec IND \uc2e0\uccad \uc808\ucc28\ub97c \uc9c0\uc6d0\ubc1b\uae30\ub85c \ud588\uc2b5\ub2c8\ub2e4. \uc774\ub7ec\ud55c CDMO\ub4e4\uc758 \uc801\uadf9\uc801\uc778 \ud65c\ub3d9\uc740 \uc2dc\uc7a5 \uc131\uc7a5\uc5d0 \ud06c\uac8c \uae30\uc5ec\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>\ub610\ud55c, 2023\ub144 4\uc6d4\uc5d0 \ubc1c\ud45c\ub41c \uc81c20\ucc28 \uc0dd\ubb3c\uc81c\uc57d \uc81c\uc870 \uc5ed\ub7c9 \ubc0f \uc0dd\uc0b0 \uc5f0\ub840 \ubcf4\uace0\uc11c \ubc0f \uc124\ubb38\uc870\uc0ac\uc5d0 \ub530\ub974\uba74, 2023\ub144\uc5d0\ub294 \uc0dd\ubb3c\uc81c\uc57d \uc751\ub2f5\uc790\uc758 86.9%\uac00 \ucd5c\uc18c\ud55c \uc77c\ubd80 \ud65c\ub3d9\uc744 \uc544\uc6c3\uc18c\uc2f1\ud588\ub2e4\uace0 \ubcf4\uace0\ud588\uc73c\uba70, \uc774\ub294 2022\ub144\uc758 82.6%\ubcf4\ub2e4 \uc99d\uac00\ud55c \uc218\uce58\uc785\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc0dd\ubb3c\uc81c\uc57d \uc544\uc6c3\uc18c\uc2f1\uc758 \uc99d\uac00\ub294 IND CDMO \uc2dc\uc7a5\uc5d0 \uae0d\uc815\uc801\uc778 \uc601\ud5a5\uc744 \ubbf8\uce60 \uac83\uc785\ub2c8\ub2e4.<\/p>\n<p>3. \uc2dc\uc7a5 \uc81c\uc57d<\/p>\n<p>\uadf8\ub7ec\ub098 \uc544\uc6c3\uc18c\uc2f1\uacfc \uad00\ub828\ub41c \uaddc\uc81c \uc900\uc218 \ubb38\uc81c\ub294 \uc7a5\uae30\uc801\uc73c\ub85c \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud560 \uc218 \uc788\ub294 \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4. \ubcf5\uc7a1\ud55c \uaddc\uc81c \ud658\uacbd\uacfc \uac01\uad6d\uc758 \uc0c1\uc774\ud55c \uaddc\uc815\uc740 CDMO \ubc0f \uc758\ub8b0 \uae30\uc5c5 \ubaa8\ub450\uc5d0\uac8c \ub3c4\uc804 \uacfc\uc81c\uac00 \ub420 \uc218 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>4. \uc2dc\uc7a5 \uc138\ubd84\ud654<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 IND CDMO \uc2dc\uc7a5\uc744 \ub2e4\uc74c\uacfc \uac19\uc774 \uc138\ubd84\ud654\ud558\uc5ec \ubd84\uc11d\ud569\ub2c8\ub2e4:<br \/>\n*   \uc81c\ud488\ubcc4: \uc800\ubd84\uc790(Small Molecule), \uace0\ubd84\uc790(Large Molecule)<br \/>\n*   \uc11c\ube44\uc2a4\ubcc4: \uacc4\uc57d \uac1c\ubc1c(Contract Development), \uacc4\uc57d \uc81c\uc870(Contract Manufacturing)<br \/>\n*   \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4: \uc81c\uc57d \ud68c\uc0ac(Pharmaceutical Companies), \uc0dd\uba85\uacf5\ud559 \ud68c\uc0ac(Biotechnology Companies), \uae30\ud0c0(Others)<br \/>\n*   \uc9c0\uc5ed\ubcc4: \ubd81\ubbf8(North America), \uc720\ub7fd(Europe), \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591(Asia-Pacific), \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74(The Middle East and Africa), \ub0a8\ubbf8(South America)<\/p>\n<p>5. \uc8fc\uc694 \uc2dc\uc7a5 \ub3d9\ud5a5 \ubc0f \ud1b5\ucc30<\/p>\n<p>5.1. \uacc4\uc57d \uc81c\uc870(Contract Manufacturing) \ubd80\ubb38\uc758 \uc131\uc7a5<\/p>\n<p>\uc81c\uc57d \uc758\uc57d\ud488\uc740 \ubcf5\uc7a1\ud55c \uad6c\uc870\ub97c \uac00\uc9c0\uace0 \uc788\uc5b4 \uae30\uc5c5\ub4e4\uc774 \ub300\ub7c9 \uc0dd\uc0b0 \uc2dc \ud2b9\uc815 \uae30\uc220 \ubc0f \uc7a5\ube44 \uc694\uad6c \uc0ac\ud56d\uc744 \ucda9\uc871\ud558\uae30 \uc5b4\ub824\uc6b4 \uacbd\uc6b0\uac00 \ub9ce\uc2b5\ub2c8\ub2e4. \uc774\ub85c \uc778\ud574 \ub9ce\uc740 \uae30\uc5c5\uc774 \uc804\ubb38\uc131\uc744 \uac16\ucd98 CDMO\uc758 \uacc4\uc57d \uc81c\uc870 \ud504\ub85c\uc138\uc2a4\ub97c \uc120\ud0dd\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774 \ubd80\ubb38\uc758 \uc131\uc7a5\uc740 \uae30\uc5c5\ub4e4\uc758 \uc804\ub7b5\uc801 \ud65c\ub3d9 \uc99d\uac00\uc640 \uc81c\uc57d \ubc0f \uc0dd\uba85\uacf5\ud559 \ubd84\uc57c\uc5d0\uc11c \uacc4\uc57d \uc81c\uc870\uc5d0 \ub300\ud55c \uc218\uc694 \uc99d\uac00\uc5d0 \uc758\ud574 \uc8fc\ub3c4\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc608\ub97c \ub4e4\uc5b4, 2022\ub144 5\uc6d4 ALSA Ventures\ub294 Lonza\uc640 \ud611\ub825\ud558\uc5ec ALSA\uc758 \uc804\uc784\uc0c1 \ubc0f \ucd08\uae30 \uc784\uc0c1 \uc0dd\uba85\uacf5\ud559 \uc81c\ud488 \uac1c\ubc1c\uc744 \uc9c0\uc6d0\ud558\uace0 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c \ubc0f \uc800\ubd84\uc790 \uc758\uc57d\ud488 \ud6c4\ubcf4 \ubb3c\uc9c8\uc744 \uc81c\uc870\ud558\uae30\ub85c \ud588\uc2b5\ub2c8\ub2e4. \uc774 \ud611\ub825\uc740 \ucd08\uae30 \uc704\ud5d8 \uc644\ud654, \uac1c\ubc1c \ubc0f \uc81c\uc870 \uc11c\ube44\uc2a4\ub97c \uc81c\uacf5\ud568\uc73c\ub85c\uc368 \ubbf8\ub798 \uce58\ub8cc\ubc95\uc758 \uc131\uacf5 \uac00\ub2a5\uc131\uc744 \ud06c\uac8c \ub192\uc774\ub294 \uac83\uc744 \ubaa9\ud45c\ub85c \ud569\ub2c8\ub2e4.<\/p>\n<p>\ub610\ud55c, 2022\ub144 9\uc6d4, Bora Pharmaceutical Laboratories Inc.\ub294 \ub300\ub9cc\uc758 \uc2e0\uc57d \uac1c\ubc1c \ud68c\uc0ac\uc778 TaiRx Inc.\uc640 \ud611\ub825\ud558\uc5ec \uc0c8\ub85c\uc6b4 \ud56d\uc554\uc81c CVM-1118\uc744 \uc81c\uc870\ud588\uc2b5\ub2c8\ub2e4. CVM-1118\uc740 \ub2e4\uc591\ud55c \uc778\uac04 \uc554\uc138\ud3ec\uc8fc\uc5d0\uc11c \uc0c1\ub2f9\ud55c \ud56d\uc554 \ud6a8\ub2a5, \ub113\uc740 \uc548\uc804 \ub9c8\uc9c4, \uadf8\ub9ac\uace0 \uc554 \ud2b9\uc774\uc801 \uad6c\uc131 \uc694\uc18c\ub97c \ud45c\uc801\uc73c\ub85c \ud558\ub294 \ub2e4\uc591\ud55c \uc791\uc6a9 \ubc29\uc2dd\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4. \uc774\ub7ec\ud55c CDMO\ub4e4\uc758 \uc2e0\uc18d\ud55c \uc6c0\uc9c1\uc784\uc73c\ub85c \uc778\ud574 \uacc4\uc57d \uc81c\uc870 \ubd80\ubb38\uc740 \uc608\uce21 \uae30\uac04 \ub3d9\uc548 \ud06c\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>5.2. \ubd81\ubbf8 \uc2dc\uc7a5\uc758 \uc0c1\ub2f9\ud55c \uc810\uc720\uc728 \uc720\uc9c0<\/p>\n<p>\ubd81\ubbf8 \uad6d\uac00\ub4e4\uc740 \uc798 \uad6c\ucd95\ub41c \uc81c\uc57d \ubc0f \uc0dd\uba85\uacf5\ud559 \ubd80\ubb38\uc744 \ubcf4\uc720\ud558\uace0 \uc788\uc5b4 IND CDMO \uc2dc\uc7a5 \uc131\uc7a5\uc5d0 \uc720\ub9ac\ud55c \ud658\uacbd\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \ub610\ud55c, \uc774\ub4e4 \uad6d\uac00\ub294 R&#038;D \ud65c\ub3d9\uc5d0 \uc0c1\ub2f9\ud55c \ud22c\uc790\ub97c \ud574\uc654\uc73c\uba70, \uc774\ub294 \uc774 \uc9c0\uc5ed\uc758 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \ucd09\uc9c4\ud558\ub294 \uc8fc\uc694 \uc694\uc778\uc785\ub2c8\ub2e4. \uc0dd\ubb3c\uc81c\uc57d \uc758\uc57d\ud488 \uc0dd\uc0b0\uc744 \ucd09\uc9c4\ud558\uae30 \uc704\ud55c \uc81c\uc870 \uc2dc\uc124 \ud655\uc7a5 \ubc0f \ucd9c\uc2dc\uc5d0 \ub300\ud55c \uad00\uc2ec \uc99d\uac00\ub294 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \ub354\uc6b1 \uac00\uc18d\ud654\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc608\ub97c \ub4e4\uc5b4, 2023\ub144 9\uc6d4 \uce98\ub9ac\ud3ec\ub2c8\uc544 \uae30\ubc18\uc758 \uc784\uc0c1 \ub2e8\uacc4 \uc0dd\uba85\uacf5\ud559 \ud68c\uc0ac\uc778 Bolt\ub294 \uc0bc\uc131\ubc14\uc774\uc624\ub85c\uc9c1\uc2a4\uc640 IND \uc81c\ucd9c\uc744 \uc704\ud55c \ucd08\uae30 \ub2e8\uacc4 \uc2e0\uc57d \uac1c\ubc1c \uc2e4\ud589\uc744 \uac00\uc18d\ud654\ud558\uae30 \uc704\ud574 \ud30c\ud2b8\ub108\uc2ed\uc744 \ub9fa\uc5c8\uc2b5\ub2c8\ub2e4. \uc774\ub7ec\ud55c \ud30c\ud2b8\ub108\uc2ed\uc744 \ud1b5\ud574 \ubbf8\uad6d \uc2dc\uc7a5\uc740 \uc0c1\ub2f9\ud55c \uc131\uc7a5\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc784\uc0c1\uc2dc\ud5d8\uc6a9 \uc2e0\uc57d \uad00\ub828 \uae30\uc5c5\ub4e4\uc740 \ubbf8\uad6d \uc2dd\ud488\uc758\uc57d\uad6d(FDA)\uc758 &#8216;Safe To Proceed&#8217; \uc2b9\uc778 \uc11c\ud55c\uc744 \uae30\ub2e4\ub9ac\ub294 \ub370 \uc2dc\uac04\uc774 \ub9ce\uc774 \uc18c\uc694\ub418\ubbc0\ub85c, \uc784\uc0c1 \uc5f0\uad6c\ub97c \uc704\ud55c \uc0ac\uc804 IND \ub77c\ubca8\ub9c1 \ubc0f \ud3ec\uc7a5 \uc804\ub7b5\uc744 \ud65c\uc6a9\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. PCI Pharma Services\uc640 \uac19\uc740 \uae30\uc5c5\ub4e4\uc740 \uce90\ub098\ub2e4\uc5d0\uc11c CDMO\uc640 \ud611\ub825\ud558\uc5ec \uc774\ub7ec\ud55c \uc11c\ube44\uc2a4\ub97c \uc81c\uacf5\ud558\uace0 \uc788\uc73c\uba70, PCI Pharma Services\ub294 \uce90\ub098\ub2e4\uc5d0\uc11c \uc784\uc0c1\uc2dc\ud5d8 \uc11c\ube44\uc2a4\ub97c \uc81c\uacf5\ud558\ub294 \uc8fc\uc694 \ud68c\uc0ac \uc911 \ud558\ub098\uc785\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uae30\uc5c5\ub4e4\uc758 \ub4f1\uc7a5\uc740 \uce90\ub098\ub2e4\uc758 IND CDMO \uc2dc\uc7a5\uc744 \ud06c\uac8c \uc131\uc7a5\uc2dc\ud0ac \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \ub530\ub77c\uc11c \uae30\uc5c5 \ud65c\ub3d9 \uc99d\uac00\uc640 R&#038;D\uc5d0 \ub300\ud55c \ub192\uc740 \ud22c\uc790\ub85c \uc778\ud574 \uc608\uce21 \uae30\uac04 \ub3d9\uc548 \ubd81\ubbf8 \uc9c0\uc5ed \uc2dc\uc7a5\uc740 \uc9c0\uc18d\uc801\uc73c\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n<p>6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<p>\uc784\uc0c1\uc2dc\ud5d8\uc6a9 \uc2e0\uc57d CDMO \uc2dc\uc7a5\uc740 \uc804 \uc138\uacc4\uc801\uc73c\ub85c \uc5ec\ub7ec \uae30\uc5c5\uc774 \ud65c\ub3d9\ud558\ub294 \uc900\ud1b5\ud569(semi-consolidated) \uc2dc\uc7a5\uc785\ub2c8\ub2e4. \ub300\ubd80\ubd84\uc758 \uae30\uc5c5\uc740 \uc2dc\uc7a5\uc5d0\uc11c \uc9c0\uc18d\uc801\uc778 \uc131\uc7a5\uc744 \uc704\ud574 \uc778\uc218 \ud569\ubcd1, \ud611\ub825, \ud30c\ud2b8\ub108\uc2ed\uacfc \uac19\uc740 \uc804\ub7b5\uc801 \ud65c\ub3d9\uc5d0 \ucc38\uc5ec\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc8fc\uc694 \uc2dc\uc7a5 \ucc38\uc5ec\uc790\ub85c\ub294 Lonza, Charles River Laboratories International Inc., Labcorp Corporation, Recipharm AB, Syneous Health \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>7. \ucd5c\uadfc \uc0b0\uc5c5 \ubc1c\uc804<\/p>\n<p>*   2023\ub144 9\uc6d4: Societal CDMO Inc.\ub294 \uc5ec\ub7ec \uae30\uc874 \uace0\uac1d\uacfc\uc758 \uc0c8\ub85c\uc6b4 \ud504\ub85c\uc81d\ud2b8 \ud655\uc7a5 \uacc4\uc57d\uc744 \ubc1c\ud45c\ud588\uc2b5\ub2c8\ub2e4. \uc774\ub294 \uae30\uc874 \uad00\uacc4\uc758 \uc9c0\uc18d\uc801\uc778 \uac15\ud654 \ubc0f \uc131\uc219\uc744 \ud1b5\ud574 \ub9e4\ucd9c \uc131\uc7a5\uc744 \uc774\ub04c\uc5b4\ub0b4\ub294 Societal\uc758 \uc5ed\ub7c9\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4.<br \/>\n*   2023\ub144 4\uc6d4: Lonza\ub294 \uc774\uc911 \ud2b9\uc774\uc131 \ud56d\uccb4\uc5d0 \uc911\uc810\uc744 \ub454 \ud55c\uad6d\uc758 \uc120\uad6c\uc801\uc778 \uc0dd\ubb3c\ud559 \uc81c\uc81c \ud68c\uc0ac\uc778 ABL Bio\uc640 \uacc4\uc57d\uc744 \uccb4\uacb0\ud588\uc2b5\ub2c8\ub2e4. \uc774 \ud611\ub825\uc744 \ud1b5\ud574 Lonza\ub294 ABL Bio\uc5d0 IND \uc2e0\uccad\uc744 \uc9c0\uc6d0\ud558\uae30 \uc704\ud55c \uc5d4\ub4dc\ud22c\uc5d4\ub4dc \uc194\ub8e8\uc158\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc774 \ubcf4\uace0\uc11c\ub294 \uc784\uc0c1\uc2dc\ud5d8\uc6a9 \uc2e0\uc57d(Investigational New Drug, IND) \uc704\ud0c1\uac1c\ubc1c\uc0dd\uc0b0(CDMO) \uc2dc\uc7a5\uc5d0 \ub300\ud55c \ud3ec\uad04\uc801\uc778 \ubd84\uc11d\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. IND\ub294 \ubbf8\uad6d \uc2dd\ud488\uc758\uc57d\uad6d(FDA)\uacfc \uac19\uc740 \uaddc\uc81c \ub2f9\uad6d\uc758 \uc2b9\uc778\uc744 \ubc1b\uc9c0 \uc54a\uc740 \ucd08\uae30 \uac1c\ubc1c \ub2e8\uacc4\uc758 \uc758\uc57d\ud488\uc744 \uc758\ubbf8\ud558\uba70, IND \uc9c0\uc704\ub294 \uc81c\uc57d\ud68c\uc0ac\uac00 \uc778\uccb4 \ub0b4 \uc548\uc804\uc131\uacfc \uc720\ud6a8\uc131\uc744 \ud3c9\uac00\ud558\uae30 \uc704\ud55c \uc784\uc0c1\uc2dc\ud5d8\uc744 \uc218\ud589\ud560 \uc218 \uc788\ub3c4\ub85d \ud569\ub2c8\ub2e4. \ubcf8 \ubcf4\uace0\uc11c\ub294 IND CDMO \uc2dc\uc7a5\uc758 \uc815\uc758, \ubc94\uc704, \uc5f0\uad6c \ubc29\ubc95\ub860, \uc2dc\uc7a5 \uc5ed\ud559, \uc138\ubd84\ud654, \uacbd\uc7c1 \ud658\uacbd \ubc0f \ubbf8\ub798 \ub3d9\ud5a5\uc744 \uc0c1\uc138\ud788 \ub2e4\ub8f9\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uaddc\ubaa8 \uce21\uba74\uc5d0\uc11c, IND CDMO \uc2dc\uc7a5\uc740 2024\ub144 44\uc5b5 3\ucc9c\ub9cc \ub2ec\ub7ec\ub85c \ucd94\uc815\ub418\uc5c8\uc73c\uba70, 2025\ub144\uc5d0\ub294 47\uc5b5 4\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0 \uc774\ub97c \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc774\ud6c4 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 6.55%\ub85c \uc131\uc7a5\ud558\uc5ec 2030\ub144\uc5d0\ub294 65\uc5b5 1\ucc9c\ub9cc \ub2ec\ub7ec \uaddc\ubaa8\uc5d0 \ub3c4\ub2ec\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5\uc758 \uc8fc\uc694 \uc131\uc7a5 \ub3d9\ub825\uc73c\ub85c\ub294 \uc81c\uc57d \uc0b0\uc5c5 \ub0b4 \uc784\uc0c1\uc2dc\ud5d8\uc6a9 \uc2e0\uc57d \uc2e0\uccad(IND Applications)\uc758 \uc99d\uac00\uc640 \uc5f0\uad6c \uac1c\ubc1c(R&#038;D) \ud22c\uc790 \ud655\ub300\uac00 \uaf3d\ud799\ub2c8\ub2e4. \ubc18\uba74, \uc544\uc6c3\uc18c\uc2f1\uacfc \uad00\ub828\ub41c \uaddc\uc81c \uc900\uc218 \ubb38\uc81c(Compliance Issues)\ub294 \uc2dc\uc7a5 \uc131\uc7a5\uc758 \uc81c\uc57d \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubcf4\uace0\uc11c\ub294 \ub610\ud55c \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611, \uad6c\ub9e4\uc790 \ubc0f \uacf5\uae09\uc790\uc758 \uad50\uc12d\ub825, \ub300\uccb4\uc7ac\uc758 \uc704\ud611, \uacbd\uc7c1 \uac15\ub3c4 \ub4f1\uc744 \ubd84\uc11d\ud558\ub294 Porter\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d\uc744 \ud1b5\ud574 \uc2dc\uc7a5\uc758 \uacbd\uc7c1 \uc5ed\ud559\uc744 \uc2ec\uce35\uc801\uc73c\ub85c \uc870\uba85\ud569\ub2c8\ub2e4.<\/p>\n<p>IND CDMO \uc2dc\uc7a5\uc740 \uc81c\ud488, \uc11c\ube44\uc2a4, \ucd5c\uc885 \uc0ac\uc6a9\uc790 \ubc0f \uc9c0\uc5ed\ubcc4\ub85c \uc138\ubd84\ud654\ub418\uc5b4 \ubd84\uc11d\ub429\ub2c8\ub2e4.<br \/>\n\uc81c\ud488\ubcc4\ub85c\ub294 \uc18c\ubd84\uc790(\uc6d0\ub8cc\uc758\uc57d\ud488(API), \uc644\uc81c\uc758\uc57d\ud488)\uc640 \ub300\ubd84\uc790(\ud3ec\uc720\ub958 \uc138\ud3ec \uae30\ubc18, \ubbf8\uc0dd\ubb3c \uae30\ubc18, \uae30\ud0c0)\ub85c \uad6c\ubd84\ub429\ub2c8\ub2e4.<br \/>\n\uc11c\ube44\uc2a4\ubcc4\ub85c\ub294 \uc704\ud0c1 \uac1c\ubc1c(Contract Development)\uacfc \uc704\ud0c1 \uc0dd\uc0b0(Contract Manufacturing)\uc73c\ub85c \ub098\ub269\ub2c8\ub2e4.<br \/>\n\ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4\ub85c\ub294 \uc81c\uc57d \ud68c\uc0ac, \uc0dd\uba85\uacf5\ud559 \ud68c\uc0ac \ubc0f \uae30\ud0c0\ub85c \ubd84\ub958\ub429\ub2c8\ub2e4.<br \/>\n\uc9c0\uc5ed\ubcc4\ub85c\ub294 \ubd81\ubbf8(\ubbf8\uad6d, \uce90\ub098\ub2e4, \uba55\uc2dc\ucf54), \uc720\ub7fd(\ub3c5\uc77c, \uc601\uad6d, \ud504\ub791\uc2a4, \uc774\ud0c8\ub9ac\uc544, \uc2a4\ud398\uc778 \ub4f1), \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591(\uc911\uad6d, \uc77c\ubcf8, \uc778\ub3c4, \ud55c\uad6d \ub4f1), \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8\ub85c \uad11\ubc94\uc704\ud558\uac8c \ubd84\uc11d\ub429\ub2c8\ub2e4. \ud2b9\ud788, \ubd81\ubbf8\ub294 2025\ub144 \uac00\uc7a5 \ud070 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \ucc28\uc9c0\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 \uc608\uce21 \uae30\uac04(2025-2030\ub144) \ub3d9\uc548 \uac00\uc7a5 \ub192\uc740 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub418\uc5b4 \uc911\uc694\ud55c \uc131\uc7a5 \ub3d9\ub825\uc73c\ub85c \ubd80\uc0c1\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd \ubd84\uc11d\uc5d0\ub294 Labcorp Corporation, Charles River Laboratories Inc., Cambrex Corporation, IQVIA Holdings Inc., Syneos Health, Lonza, Catalent, Recipharm AB, Siegfried Holding AG, Thermo Fisher Scientific Inc. \ub4f1 \uc8fc\uc694 \uae30\uc5c5\ub4e4\uc758 \ud504\ub85c\ud544\uc774 \ud3ec\ud568\ub429\ub2c8\ub2e4. \uc774\ub4e4 \uae30\uc5c5\uc758 \uc0ac\uc5c5 \uac1c\uc694, \uc7ac\ubb34, \uc81c\ud488 \ubc0f \uc804\ub7b5, \ucd5c\uadfc \uac1c\ubc1c \uc0ac\ud56d \ub4f1\uc774 \ub2e4\ub8e8\uc5b4\uc838 \uc2dc\uc7a5 \ub0b4 \uc8fc\uc694 \ud50c\ub808\uc774\uc5b4\ub4e4\uc758 \ub3d9\ud5a5\uc744 \ud30c\uc545\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uc804 \uc138\uacc4 \uc8fc\uc694 \uc9c0\uc5ed\uc758 17\uac1c\uad6d\uc5d0 \ub300\ud55c \uc2dc\uc7a5 \uaddc\ubaa8\uc640 \ub3d9\ud5a5\uc744 \ucd94\uc815\ud558\uba70, \ubaa8\ub4e0 \uc138\uadf8\uba3c\ud2b8\uc5d0 \ub300\ud55c \uac00\uce58(USD)\ub97c \uc81c\uacf5\ud568\uc73c\ub85c\uc368 \uc2dc\uc7a5 \ucc38\uc5ec\uc790\ub4e4\uc774 IND CDMO \uc2dc\uc7a5\uc758 \ud604\uc7ac \uc0c1\ud0dc\uc640 \ubbf8\ub798 \uae30\ud68c \ubc0f \ub3d9\ud5a5\uc5d0 \ub300\ud55c \uc2ec\uce35\uc801\uc778 \uc774\ud574\ub97c \uc5bb\uc744 \uc218 \uc788\ub3c4\ub85d \uc9c0\uc6d0\ud569\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-39977","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/39977"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=39977"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/39977\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=39977"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=39977"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=39977"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}